Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesInterferon- beta1b Treatment in Neuromyelitis Optica
European Neurology, 07/07/09
Tanaka M et al. - The effects of interferon-beta1b (IFN-beta1b) administration in multiple sclerosis (MS) patients have been confirmed, however, those in neuromyelitis optica (NMO) patients have not been shown. In NMO patients, IFN-beta1b treatment was not effective in reducing the relapse number and the disability progression.
Related Articles
Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica
Multiple Sclerosis, 11/18/09
Relevance Score: 64%%
Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
Therapeutic Advances in Neurological Disorders, 11/10/09
Relevance Score: 62%%
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Self-reported Memory Problems in Multiple Sclerosis: Influence of Psychiatric Status and Normative Dissociative Experiences
Archives of Clinical Neurospsychology, 12/07/09
MRI-based functional neuroimaging in ALS: An update
Amyotrophic Lateral Sclerosis, 12/07/09
Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease
Amyotrophic Lateral Sclerosis, 12/07/09
Sponsor
Article Search
Sponsor